Lu Timothy - 14 Sep 2021 Form 4 Insider Report for DICE Therapeutics, Inc.

Role: CMO
Signature: /s/ Scott Robertson as attorney-in-fact for Timothy Lu
Issuer symbol: N/A
Transactions as of: 14 Sep 2021
Net transactions value: $0
Form type: 4
Filing time: 16 Sep 2021, 21:24:31 UTC
Next filing: 19 Apr 2022
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
holding	DICE	Common Stock						162,285	14 Sep 2021	Direct	F1, F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	DICE	Stock Option (right to buy)	Award	$0	+31,304		$0.000000	31,304	14 Sep 2021	Common Stock	31,304	$17.00	Direct	F3
transaction	DICE	Stock Option (right to buy)	Award	$0	+25,593		$0.000000	25,593	14 Sep 2021	Common Stock	25,593	$17.00	Direct	F4
transaction	DICE	Stock Option (right to buy)	Award	$0	+25,817		$0.000000	25,817	14 Sep 2021	Common Stock	25,817	$17.00	Direct	F5
transaction	DICE	Stock Option (right to buy)	Award	$0	+17,350		$0.000000	17,350	14 Sep 2021	Common Stock	17,350	$17.00	Direct	F5

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The number of shares of Common Stock reported in the Reporting Holder's Form 3 reflected the conversion of derivative securities based on the midpoint of the Issuer's initial public offering range of $16.00 per share. The number of shares of Common Stock reflected in this Form 4 reflects the adjusted number of shares issued based on the higher initial public offering price of $17.00 per share, and does not reflect a disposition of shares.
F2	Certain of the shares are subject to the Issuer's right of repurchase if underlying vesting conditions are not met.
F3	The option vests as to 1/4 of the total shares on August 24, 2020, and then 1/48th of the total shares vest monthly, subject to the Reporting Holder's continuing employment with the Registrant.
F4	The option vests as to 1/48th of the total shares monthly, beginning January 1, 2021, subject to the Reporting Holder's continuing employment with the Registrant.
F5	The option vests as to 1/48th of the total shares monthly, beginning August 20, 2021, subject to the Reporting Holder's continuing employment with the Registrant.